Raquel Sanchez-Varo

Prof. Dr. Raquel Sanchez-Varo

Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma Bionand, Málaga, Andalusia, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Raquel Sanchez-VaroRaquel Sanchez-Varo
Raquel Sanchez-Varo
MMMarina Mejias-Ortega
Marina Mejias-Ortega
JFJuanJose Fernandez-Valenzuela
JuanJose Fernandez-Valenzuela
CNCristina Nuñez-Diaz
Cristina Nuñez-Diaz
LCLaura Caceres-Palomo
Laura Caceres-Palomo
AGAntonia Gutierrez
Antonia Gutierrez
Alzheimer’s disease (AD) constitutes the most prominent form of dementia among elderly individuals worldwide. Disease modeling using murine transgenic mice was first initiated thanks to the discovery of heritable mutations in amyloid precursor protein (APP) and presenilins (PS) genes. However, due to the repeated failure of translational applications from animal models to human patients, along with the recent advances in genetic susceptibility and our current understanding on disease biology, these models have evolved over time in an attempt to better reproduce the complexity of this devastating disease and improve their applicability. In this review, we provide a comprehensive overview about the major pathological elements of human AD (plaques, tauopathy, synaptic damage, neuronal death, neuroinflammation and glial dysfunction), discussing the knowledge that available mouse models have provided about the mechanisms underlying human disease. Moreover, we highlight the pros and cons of current models, and the revolution offered by the concomitant use of transgenic mice and omics technologies that may lead to a more rapid improvement of the present modeling battery.

22 November 2012 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
MTManuel Torres
Manuel Torres
SJSebastian Jimenez
Sebastian Jimenez
Raquel Sanchez-VaroRaquel Sanchez-Varo
Raquel Sanchez-Varo
VNVictoria Navarro
Victoria Navarro
LTLaura Trujillo-Estrada
Laura Trujillo-Estrada
JVJavier Vitorica
Javier Vitorica
Background: Axonal pathology might constitute one of the earliest manifestations of Alzheimer disease. Axonal dystrophies were observed in Alzheimer’s patients and transgenic models at early ages. These axonal dystrophies could reflect the disruption of axonal transport and the accumulation of multiple vesicles at local points. It has been also proposed that dystrophies might interfere with normal intracellular proteolysis. In this work, we have investigated the progression of the hippocampal pathology and the possible implication in Abeta production in young (6 months) and aged (18 months) PS1(M146L)/APP(751sl) transgenic mice. Results: Our data demonstrated the existence of a progressive, age-dependent, formation of axonal dystrophies, mainly located in contact with congophilic Abeta deposition, which exhibited tau and neurofilament hyperphosphorylation. This progressive pathology was paralleled with decreased expression of the motor proteins kinesin and dynein. Furthermore, we also observed an early decrease in the activity of cathepsins B and D, progressing to a deep inhibition of these lysosomal proteases at late ages. This lysosomal impairment could be responsible for the accumulation of LC3-II and ubiquitinated proteins within axonal dystrophies. We have also investigated the repercussion of these deficiencies on the APP metabolism. Our data demonstrated the existence of an increase in the amyloidogenic pathway, which was reflected by the accumulation of hAPPfl, C99 fragment, intracellular Abeta in parallel with an increase in BACE and gamma-secretase activities. In vitro experiments, using APPswe transfected N2a cells, demonstrated that any imbalance on the proteolytic systems reproduced the in vivo alterations in APP metabolism. Finally, our data also demonstrated that Abeta peptides were preferentially accumulated in isolated synaptosomes. Conclusion: A progressive age-dependent cytoskeletal pathology along with a reduction of lysosomal and, in minor extent, proteasomal activity could be directly implicated in the progressive accumulation of APP derived fragments (and Abeta peptides) in parallel with the increase of BACE-1 and gamma-secretase activities. This retard in the APP metabolism seemed to be directly implicated in the synaptic Abeta accumulation and, in consequence, in the pathology progression between synaptically connected regions.

12 November 2013 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
LTLaura Trujillo-Estrada
Laura Trujillo-Estrada
SJSebastian Jimenez
Sebastian Jimenez
VCVanessa De Castro
Vanessa De Castro
MTManuel Torres
Manuel Torres
DBDavid Baglietto-Vargas
David Baglietto-Vargas
JVJavier Vitorica
Javier Vitorica
Alzheimer’s disease (AD) is characterized by the abnormal accumulation of extracellular beta-amyloid (Abeta) plaques, intracellular hyperphosphorylated tau, progressive synaptic alterations, axonal dystrophies, neuronal loss and the deterioration of cognitive capabilities of patients. However, no effective disease-modifying treatment has been yet developed. In this work we have evaluated whether chronic lithium treatment could ameliorate the neuropathology evolution of our well characterized PS1M146LxAPPSwe-London mice model.

Verified
Journal Article
Open access
PDF file
Juan Antonio Garcia LeonJuan Antonio Garcia Leon
Juan Antonio Garcia Leon
LCLaura Caceres-Palomo
Laura Caceres-Palomo
ESElisabeth Sanchez-Mejias
Elisabeth Sanchez-Mejias
MMMarina Mejias-Ortega
Marina Mejias-Ortega
CNCristina Nuñez-Diaz
Cristina Nuñez-Diaz
AGAntonia Gutierrez
Antonia Gutierrez
Extracellular amyloid-beta deposition and intraneuronal Tau-laden neurofibrillary tangles are prime features of Alzheimer’s disease (AD). The pathology of AD is very complex and still not fully understood, since different neural cell types are involved in the disease. Although neuronal function is clearly deteriorated in AD patients, recently, an increasing number of evidences have pointed towards glial cell dysfunction as one of the main causative phenomena implicated in AD pathogenesis. The complex disease pathology together with the lack of reliable disease models have precluded the development of effective therapies able to counteract disease progression. The discovery and implementation of human pluripotent stem cell technology represents an important opportunity in this field, as this system allows the generation of patient-derived cells to be used for disease modeling and therapeutic target identification and as a platform to be employed in drug discovery programs. In this review, we discuss the current studies using human pluripotent stem cells focused on AD, providing convincing evidences that this system is an excellent opportunity to advance in the comprehension of AD pathology, which will be translated to the development of the still missing effective therapies.

3 October 2023 in British Journal of Pharmacology
Verified
Journal Article
Open access
MBMiriam Bettinetti‐Luque
Miriam Bettinetti‐Luque
LTLaura Trujillo‐Estrada
Laura Trujillo‐Estrada
EGEduardo Garcia-Fuentes
Eduardo Garcia-Fuentes
JAJuana Andreo‐Lopez
Juana Andreo‐Lopez
Raquel Sanchez-VaroRaquel Sanchez-Varo
Raquel Sanchez-Varo
DBDavid Baglietto-Vargas
David Baglietto-Vargas
Adipose tissue has recently been recognized as an important endocrine organ that plays a crucial role in energy metabolism and in the immune response in many metabolic tissues. With this regard, emerging evidence indicates that an important crosstalk exists between the adipose tissue and the brain. However, the contribution of adipose tissue to the development of age‐related diseases, including Alzheimer's disease, remains poorly defined. New studies suggest that the adipose tissue modulates brain function through a range of endogenous biologically active factors known as adipokines, which can cross the blood–brain barrier to reach the target areas in the brain or to regulate the function of the blood–brain barrier. In this review, we discuss the effects of several adipokines on the physiology of the blood–brain barrier, their contribution to the development of Alzheimer's disease and their therapeutic potential.LINKED ARTICLES: This article is part of a themed issue From Alzheimer's Disease to Vascular Dementia: Different Roads Leading to Cognitive Decline. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.6/issuetoc

19 February 2025 in JMIR Medical Education
Verified
Journal Article
Open access
Alejandro Escamilla-SánchezAlejandro Escamilla-Sánchez
Alejandro Escamilla-Sánchez
JLJuan Antonio López-Villodres
Juan Antonio López-Villodres
CACarmen Alba-Tercedor
Carmen Alba-Tercedor
MOMaría Victoria Ortega-Jiménez
María Victoria Ortega-Jiménez
FDFrancisca Rius Diaz
Francisca Rius Diaz
DFDiego Teófilo Bermúdez Flores
Diego Teófilo Bermúdez Flores
Background: Student development is currently taking place in an environment governed by new technologies and social media. Some platforms, such as Instagram or X (previously known as “Twitter”), have been incorporated as additional tools for teaching and learning processes in higher education, especially in the framework of image-based applied disciplines, including radiology and pathology. Nevertheless, the role of social media in the teaching of core subjects such as histology has hardly been studied, and there are very few reports on this issue. Objective: The aim of this work was to investigate the impact of implementing social media on the ability to learn human histology. For this purpose, a set of voluntary e-learning activities was shared on Instagram as a complement to traditional face-to-face teaching. Methods: The proposal included questionnaires based on multiple-choice questions, descriptions of histological images, and schematic diagrams about the subject content. These activities were posted on an Instagram account only accessible by second-year medical students from the University of Malaga. In addition, students could share their own images taken during the laboratory practice and interact with their peers. Results: Of the students enrolled in Human Histology 2, 85.6% (143/167) agreed to participate in the platform. Most of the students valued the initiative positively and considered it an adequate instrument to improve their final marks. Specifically, 68.5% (98/143) of the student body regarded the multiple-choice questions and image-based questions as the most useful activities. Interestingly, there were statistically significant differences between the marks on the final exam (without considering other evaluation activities) for students who participated in the activity compared with those who did not or barely participated in the activity (P<.001). There were no significant differences by degree of participation between the more active groups. Conclusions: These results provide evidence that incorporating social media may be considered a useful, easy, and accessible tool to improve the learning of human histology in the context of medical degrees.